Fifty 1 Labs, Inc. (FITY)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0001 (25.00%)
At close: Jan 23, 2026
Fifty 1 Labs Revenue
Fifty 1 Labs had revenue of $998.05K in the quarter ending March 31, 2011, a decrease of -20.87%. This brings the company's revenue in the last twelve months to $4.08M, down -29.40% year-over-year. In the fiscal year ending June 30, 2010, Fifty 1 Labs had annual revenue of $5.11M, down -5.64%.
Revenue (ttm)
4.08M
Revenue Growth
-29.40%
P/S Ratio
0.11
Revenue / Employee
163.06K
Employees
25
Market Cap
443.45K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2010 | 5.11M | -305.13K | -5.64% |
| Jun 30, 2009 | 5.41M | 905.69K | 20.10% |
| Jun 30, 2008 | 4.51M | -2.44M | -35.11% |
| Jun 30, 2007 | 6.94M | -4.74M | -40.57% |
| Jun 30, 2006 | 11.68M | 9.59M | 458.26% |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ecofibre | 17.56M |
| Petros Pharmaceuticals | 5.11M |
| Endexx | 4.64M |
| Stemtech | 3.73M |
| Demand Brands | 165.00K |
| Branded Legacy | 87.65K |
| Neutra | 66.07K |
| ViaDerma | 44.69K |
Fifty 1 Labs News
- 19 days ago - Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace - GlobeNewsWire
- 3 months ago - Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer - GlobeNewsWire
- 4 months ago - Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. - GlobeNewsWire
- 4 months ago - Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB - GlobeNewsWire
- 5 months ago - Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence - GlobeNewsWire
- 5 months ago - Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 - GlobeNewsWire
- 5 months ago - Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies - GlobeNewsWire
- 5 months ago - Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation - GlobeNewsWire